Nuwellis (NUWE) Shares Outstanding (Weighted Average) (2011 - 2026)

Nuwellis (NUWE) reported Shares Outstanding (Weighted Average) of $2.1 million for Q1 2026, up 1892.47% on a YoY basis from $104142.0 in Q1 2025, and up 200.66% quarter-over-quarter from $690145.0 in Q4 2025.

Nuwellis (NUWE) Shares Outstanding (Weighted Average) (2011 - 2026) Analysis & Trends

Nuwellis has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $2.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1892.47% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 1892.47% YoY), and the FY2025 full-year result was $690145.0, up 2083.93% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $2.1 million, up from $690145.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $2.1 million in Q1 2026, with the low at $31601.0 in Q4 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $336554.8 across 5 years, with a median of $105000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) sank 98.39% — and 2025, when it jumped 2083.93%.
  • Nuwellis' Shares Outstanding (Weighted Average) stood at $174000.0 in 2022, then tumbled by 67.74% to $56126.0 in 2023, then tumbled by 43.7% to $31601.0 in 2024, then jumped by 2083.93% to $690145.0 in 2025, then jumped by 200.66% to $2.1 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $2.1 million (Q1 2026), $690145.0 (Q4 2025), and $382000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 382.90 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 456.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 98.20 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn 2.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.08 Mn
Dec 31, 2025 690,145.00
Sep 30, 2025 382,000.00
Jun 30, 2025 205,839.00
Mar 31, 2025 104,142.00
Dec 31, 2024 31,601.00
Sep 30, 2024 204,710.00
Jun 30, 2024 86,261.00
Mar 31, 2024 179,608.00
Dec 31, 2023 56,126.00
Sep 30, 2023 53,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 1.13 Mn
Dec 31, 2022 174,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 105,000.00
Mar 31, 2022 105,000.00
Dec 31, 2021 69,000.00
Sep 30, 2021 5.62 Mn
Jun 30, 2021 6.53 Mn